However, clinical trials showing positive kidney-protective efficacy in patients with CKD without type 2 diabetes included only patients with high urine albumin–creatinine ratio (UACR; >200 mg/g) [11, 15], resulting in little evidence for patients with low UACR [16]. Here, ALB is linked to type 2 diabetes mellitus.